TP53 and hepatocellular carcinoma: In addition, future studies should focus on the hallmarks of MDM2–p53 axis dysfunction in the chronic progressive liver disease that is strongly associated with HCC initiation and development, which will help to diagnose and treat the HCC at vulnerable early stages.